Antistaphylococcal activity of ACHN-490 tested alone and in combination with other agents by time-kill assay

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 5, 2010, Pages 2258-2261

  Lin, Gengrong ^a   Ednie, Lois M ^a   Appelbaum, Peter C ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACHN 490; AMINOGLYCOSIDE ANTIBIOTIC AGENT; CEFTOBIPROLE; DAPTOMYCIN; LINEZOLID; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; ASSAY; COLONY FORMING UNIT; DRUG POTENTIATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TIME KILL ASSAY;

ACETAMIDES; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; DAPTOMYCIN; DRUG RESISTANCE, BACTERIAL; DRUG SYNERGISM; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; OXAZOLIDINONES; SISOMICIN; TIME FACTORS;

EID: 77951231541     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01350-09     Document Type: Article

References (27)

1. Adern, P. V., C. P. Montgomery, A. N. Husain, T. K. Koogler, V. Arangelovich, M. Humilier, S. Boyle-Vavra, and R. S. Daum. 2005. Staphylococcus aureus sepsis and the Waterhouse-Freiderichsen syndrome in children. N. Engl. J. Med. 353:1245-1251.
2. Aggen, J., E. Armstrong, A. Goldblum, P. Dozzo, M. Linsell, M. Gliedt, D. Hildebrandt, L. Feeney, A. Kubo, R. Matias, S. Lopez, M. Gomez, K. Wlasichuk, R. Diokno, G. Miller, and H. Moser. 2009. Synthesis, structure, and in vitro activity of the neoglycoside ACHN-490, abstr. F1-840. Abstr. 49th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
3. American Thoracic Society. 2005. Guidelines for the management of adults with hospital-acquired ventilator-associated, and healthcare-associated pneumonia. Am. J. Respir. Crit. Care Med. 171:388-416.
4. Cass, R., J. McKinnell, B. Xie, D. Karr, and D. Schmidt. 2009. Pharmacokinetics of the neoglycoside ACHN-490 in mouse, rat and dog, abstr. F1-846. Abstr. 49th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
5. Credito, K., G. Lin, and P. C. Appelbaum. 2007. Activity of daptomycin alone and in combination with rifampin and gentamicin against Staphylococcus aureus assessed by time-kill methodology. Antimicrob. Agents Chemother. 51:1504-1507.
6. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing. Approved standard M100-S19, 19th informational supplement. Clinical and Laboratory Standards Institute, Wayne, PA.
7. Cui, L., A. Iwamoto, J. Q. Lian, H. M. Neoh, T. Murayama, Y. Horikawa, and K. Hiramatsu. 2006. Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus. Antimicrob. Agents Chemother. 50:428-438.
8. Cui, L., E. Tominaga, H. M. Neoh, and K. Hiramatsu. 2006. Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus. Antimicrob. Agents Chemother. 50:1079-1082.
9. De Lassence, A., N. Hidri, J. F. Timsit, M. L. Joly-Guillou, G. Thiery, A. Boyer, P. Lable, A. Blivet, H. Kalinowski, Y. Martin, J. P. Lajonchere, and D. Dreyfuss. 2006. Control and outcome of a large outbreak of colonization and infection with glycopeptide-intermediate Staphylococcus aureus in an intensive care unit. Clin. Infect. Dis. 42:170-178.
10. Denis, O., A. Deplano, H. de Beenhouwer, M. Hallin, G. Huysmans, M. G. Garrino, Y. Glupczynski, X. Malaviolle, A. Vergison, and M. J. Streulens. 2005. Polyclonal emergence and importation of community-acquired methicillin-resistant Staphylococcus aureus strains harbouring Panton-Valentin leucocidin genes in Belgium. J. Antimicrob. Chemother. 56:1103-1106.
11. Deresinski, S. 2005. Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey. Clin. Infect. Dis. 40:562-573.
12. Endimiani, A., K. M. Hujer, A. M. Hujer, E. S. Armstrong, Y. Choudhary, J. B. Aggen, and R. A. Bonomo. 2009. ACHN-490, a neoglycoside with potent in vitro activity against multidrug-resistant Klebsiella pneumoniae isolates. Antimicrob. Agents Chemother. 53:4504-4507.
13. Francis, J. S., M. C. Doherty, U. Lopatin, C. P. Johnston, G. Sinha, T. Ross, M. Cai, N. N. Hansel, T. Perl, J. R. Ticehurst, K. Carroll, D. L. Thomas, E. Nuermberger, and J. G. Bartlett. 2005. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin. Infect. Dis. 40:100-107.
14. Garnier, F., D. Chainier, T. Walsh, A. Karlsson, A. Bolmström, C. Grelaud, M. Mounier, F. Denis, and M. C. Ploy. 2006. A 1 year surveillance study of glycopeptide-intermediate Staphylococcus aureus strains in a French hospital. J. Antimicrob. Chemother. 57:146-149.
15. Gonzalez, B. E., K. G. Hulten, M. K. Dishop, L. B. Lamberth, W. A. Hammerman, E. O. Mason, Jr., and S. L. Kaplan. 2005. Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus. Clin. Infect. Dis. 41:583-590.
16. Healy, C. M., K. G. Hulten, D. L. Palazzi, J. R. Campbell, and C. J. Baker. 2004. Emergence of new strains of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Clin. Infect. Dis. 39:1460-1466.
17. Jacqueline, C., J. Caillon, V. Le Mabecque, A. F. Miègeville, P. Y. Donnio, D. Bugnon, and G. Potel. 2003. In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods. J. Antimicrob. Chemother. 51:857-864.
18. Jones, R., E. Armstrong, J. Aggen, D. Biedenbach, and G. Miller. 2009. Antimicrobial activity of ACHN-490, a neoglycoside, tested against a contemporary collection of clinical isolates including problematic antimicrobialresistant phenotypes, abstr. F1-846a. Abstr. 49th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
19. Julian, K., K. Kosowska-Shick, C. Whitener, M. Roos, H. Labischinski, A. Rubio, L. Parent, L. Ednie, L. Koeth, T. Bogdanovich, and P. C. Appelbaum. 2007. Characterization of a daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus strain in a patient with endocarditis. Antimicrob. Agents Chemother. 51:3445-3448.
20. Kazakova, S. V., J. C. Hageman, M. Matava, A. Srinivasan, L. Phelan, B. Garfinkel, T. Boo, S. McAllister, J. Anderson, B. Jensen, D. Dodson, D. Lonsway, L. K. McDougal, M. Arduino, V. J. Fraser, G. Killgore, F. C. Tenover, S. Cody, and D. B. Jernigan. 2005. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N. Engl. J. Med. 352:468-475.
21. Miller, L. G., F. Perdreau-Remington, G. Rieg, S. Mehdi, J. Perlroth, A. S. Bayer, A. W. Tang, T. O. Phung, and B. Spellberg. 2005. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N. Engl. J. Med. 352:1445-1453.
22. Reyes, N., J. Aggen, and C. Kostrub. 2009. In vivo efficacy of the neoglycoside ACHN-490 against Enterobacteriaceae and MRSA, abstr. F1-845. Abstr. 49th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
23. Solomkin, J. S., J. E. Mazuski, J. S. Bradley, K. A. Rodvold, E. J. Goldstein, E. J. Baron, P. J. O'Neill, A. W. Chow, E. P. Dellinger, S. R. Eachempati, S. Gorbach, M. Hilfiker, A. K. May, A. B. Nathens, R. G. Sawyer, and J. G. Bartlett. 2010. Management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin. Infect. Dis. 50:133-164.
24. Takizawa, Y., I. Taneike, S. Nakagawa, T. Oishi, Y. Nitahara, N. Iwakura, K. Ozaki, M. Takano, T. Nakayama, and T. Yamamoto. 2005. A Panton-Valentine leukocidin (PVL)-positive community-acquired methicillin-resistant Staphylococcus aureus (MRSA) strain, another such strain carrying a multiple-drug resistance plasmid, and other more-typical PVL-negative MRSA strains found in Japan. Antimicrob. Agents Chemother. 43:3356-3363.
25. Tenover, F. C., L. K. McDougal, R.V. Goering, G. Killgore, S.J. Projan, J. B. Patel, and P. M. Dunman. 2006. Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. Antimicrob. Agents Chemother. 44:108-118.
26. Tenover, F. C., L. M. Weigel, P.C. Appelbaum, L. K. McDougal, J. Chaitram, S. McAllister, N. Clark, G. Killgore, C. M. O'Hara, L. Jevitt, J. B. Patel, and B. Bozdogan. 2004. Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania. Antimicrob. Agents Chemother. 48:275-280.
27. Voyich, J. M., M. Otto, B. Mathema, K. R. Braughton, A. R. Whitney, D. Welty, R. D. Long, D. W. Dorward, D. J. Gardner, G. Lina, B. N. Kreiswirth, and F. R. DeLeo. 2006. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J. Infect. Dis. 194:1761-1770.